Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,206.80
(
2.83%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
92.78
(
-8.33%
)
Bitcoin
71,556.17
(
-0.60%
)
News Focus
News Focus
Post# of 257369
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122853
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 3434

Monday, 08/30/2004 3:05:09 PM

Monday, August 30, 2004 3:05:09 PM

Post# of 257369
>> Incidentally, authorized generics have been around for at least 10 years. <<

But they are essentially a loophole –I highly doubt that Congress intended to allow for their existence. Rather, Congress neglected to define “exclusivity” in sufficient detail in the portion of Hatch-Waxman dealing with 180-day generic exclusivity.

--
I’m hearing that EYET shares are all but impossible to borrow for shorting today. I’m glad I didn’t cover mine.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today